Cannabis acts on a network of receptors found throughout the brain and body, producing effects that range from mild euphoria and relaxation to impaired coordination, altered memory, and changes in heart rate and breathing. The specific mix of effects depends on the dose, the method of consumption, how often someone uses it, and individual biology. Because cannabinoid receptors sit in brain regions controlling mood, movement, memory, and appetite, and also in the lungs, gut, immune cells, and reproductive organs, weed touches an unusually wide set of systems at once.
How Cannabis Gets Into Your System
THC and CBD, the two most studied compounds in cannabis, bind to cannabinoid receptors called CB1 and CB2, which are present in the brain and many organs throughout the body.1PubMed Central. Mechanisms of Action and Pharmacokinetics of Cannabis CB1 receptors are especially dense in the central nervous system, concentrated in areas like the hippocampus (memory), basal ganglia (movement), amygdala (emotions), and cerebral cortex (higher-order thinking).2PubMed Central. Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks CB2 receptors show up mainly on immune cells and become more available during inflammation.3PubMed Central. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation This distribution explains why cannabis affects everything from coordination to appetite to immune function.
The route of consumption matters more than most people realize. When you smoke or vape, THC reaches the brain within seconds, peaks quickly, and starts fading within a couple of hours. When you eat an edible, the story changes. THC passes through the gut and liver before reaching the bloodstream. In the liver, enzymes convert it into a metabolite called 11-OH-THC, which crosses into the brain more readily and is more potent than THC itself. This metabolite appears in higher quantities after eating cannabis than after smoking it, which is a major reason edibles tend to feel stronger and last longer. Meanwhile, only about 6 to 10 percent of the THC in an edible actually makes it into circulation, so the onset is slower and the peak is delayed, sometimes by an hour or more.4PubMed Central. Tasty THC: Promises and Challenges of Cannabis Edibles – Section: Challenges of Edibles That lag is where a lot of accidental overconsumption happens: people eat more because they don’t feel anything yet.
Thinking, Memory, and Motor Control
The most immediate and noticeable brain effects of cannabis involve cognition and coordination. Research consistently shows impairment across a range of mental tasks, from basic motor coordination to complex skills like planning, problem-solving, decision-making, and emotional regulation.5PubMed Central. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions These effects are dose-dependent. In a study of regular users, smoking cannabis with a higher THC dose impaired performance on a virtual maze task and worsened decision-making on a gambling task, while a lower dose caused less impairment on the same tasks.6PubMed. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9-tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana
What about lasting effects on the brain’s ability to work? A large study using brain imaging found that heavy lifetime cannabis use was linked to lower brain activation during working memory tasks. The affected regions included the anterior insula, the medial prefrontal cortex, and the dorsolateral prefrontal cortex, areas heavily involved in attention and executive function. Recent use also appeared to affect performance and brain activation during motor and memory tasks, though some of those associations were weaker statistically.7JAMA Network Open. Brain Function Outcomes of Recent and Lifetime Cannabis Use The practical takeaway is that both getting high right now and having a long history of heavy use can dull your cognitive sharpness, but through partly different mechanisms.
What Happens to Brain Structure Over Time
Heavy, long-term cannabis use has been associated with measurable changes in brain anatomy, though the picture is more nuanced than a simple “weed shrinks your brain.” A longitudinal imaging study found that heavier weekly use correlated with reduced grey matter volume in the amygdala and hippocampus, regions central to emotion and memory.8PubMed Central. Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study Separate research found grey matter reductions in the medial temporal cortex, insula, and orbitofrontal cortex of regular users, with the magnitude of changes correlating with how frequently someone used cannabis in the months before the study. The age at which someone started using also influenced how large the changes were.9PubMed Central. Long-term effects of cannabis on brain structure
In people with cannabis dependence, the structural picture extends to white matter as well. One study found lower white matter integrity in tracts connecting several brain regions, and reduced grey matter thickness specifically in the precuneus, a region involved in self-awareness and memory retrieval.10Molecular Psychiatry. Brain structural changes in cannabis dependence: association with MAGL These findings are correlational, so they do not prove cannabis alone caused the changes, but they are consistent across multiple studies and tend to show up in the brain areas where CB1 receptors are most concentrated.
Why the Teenage Brain Is Especially Vulnerable
The adolescent brain is still under construction. Key processes like myelination (insulating nerve fibers to speed up signals) and synaptic pruning (trimming unnecessary connections to make the remaining ones more efficient) continue through the teenage years and into the mid-twenties. Cannabinoid receptors appear to play a role in these developmental processes and may increase in number during adolescence. Disrupting the endocannabinoid system during this window can potentially trigger a cascade of changes in brain chemistry and structure, leading to poorer cognitive and emotional outcomes later in life.11PubMed Central. Effects of Cannabis on the Adolescent Brain This is why most of the concern about cannabis use is especially pointed for people under 25. The adult brain still experiences effects, but it is not simultaneously trying to wire itself up for the first time.
The Lungs and Respiratory System
Smoking cannabis, like smoking anything, introduces hot particulate matter and combustion byproducts into the airways. Cannabis smoke irritates the bronchial tree and is strongly associated with symptoms of chronic bronchitis, along with visible signs of airway inflammation under a microscope. It also impairs the ability of immune cells in the lungs to fight off bacteria and fungi, raising the risk of respiratory infections. In people with weakened immune systems, the association with invasive pulmonary aspergillosis (a serious fungal infection) is particularly worrying.12PubMed. Effects of cannabis smoking on the respiratory system: A state-of-the-art review
Interestingly, cannabis also has a short-term bronchodilator effect, meaning it opens the airways briefly. But chronic use is associated with worse asthma control, and cannabis smoking is a risk factor for bullous lung disease, spontaneous pneumothorax (collapsed lung), and a type of allergic lung reaction. A growing number of studies also report an independent association between cannabis smoking and lung cancer. One finding that often surprises people: cannabis smoking has not been linked to the development of chronic obstructive pulmonary disease (COPD) the way tobacco has, though the evidence base is smaller and the two habits differ in typical dose and frequency.12PubMed. Effects of cannabis smoking on the respiratory system: A state-of-the-art review
Heart and Blood Pressure
Cannabis acutely raises heart rate, sometimes by 20 to 50 beats per minute in the first hour after use. This is well-established and is one of the reasons emergency room visits from cannabis involve chest discomfort or palpitations. But the question of whether long-term use causes lasting cardiovascular damage, particularly high blood pressure, is less clear-cut. A large, long-running study following young adults over many years found that cumulative lifetime cannabis exposure was not significantly associated with developing hypertension.13Lippincott Williams & Wilkins (Ovid / Hypertension). Lifetime Cannabis Use and Incident Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study That doesn’t rule out other cardiovascular risks, but it does push back against the assumption that chronic use reliably raises blood pressure.
Mental Health and the Psychosis Question
THC’s effects on mood are famously two-faced. At lower doses, many people experience relaxation and mild euphoria. At higher doses, or in people who are not regular users, THC tends to increase anxiety. Studies in people with minimal cannabis use show that both low and high THC doses increase subjective feelings of a racing heart, and that higher doses increase self-reported anxiety and nervousness in a dose-dependent way.14PubMed Central. THC, CBD, and Anxiety: A review of recent findings on the anxiolytic and anxiogenic effects of cannabis’ primary cannabinoids This is the paradox that confuses a lot of people: the same substance that some use to calm down makes others panicky, and the dose is a big part of the explanation.
The most serious psychiatric concern around cannabis is psychosis. A study of over 109,000 people found that cannabis use was associated with higher odds of psychotic experiences like auditory hallucinations and delusions, and that this association was amplified in people with higher genetic risk for schizophrenia. Among the fifth of participants with the highest genetic risk scores, ever having used cannabis was linked to roughly 1.6-fold greater odds of psychotic experiences, compared to about 1.4-fold greater odds among those with the lowest genetic risk. For delusions specifically, there was no significant association with cannabis use at all unless someone was in the top two-fifths of genetic risk.15Translational Psychiatry. Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank In other words, cannabis use does not create psychosis out of thin air, but it can bring it closer to the surface in people who are already genetically predisposed.
Sleep
Many people use cannabis specifically to fall asleep, and some studies have reported that it can increase slow-wave sleep, which is one of the deeper stages.16PubMed Central. The Effects of Cannabinoids on Sleep But a recent systematic review and meta-analysis paints a more ambiguous picture. Cannabis does not consistently alter total sleep duration, how long it takes to fall asleep, wake time during the night, sleep efficiency, or the time spent in different sleep stages. Earlier studies that suggested THC suppresses REM sleep were mostly small-scale trials using high doses with significant methodological limitations; more recent and larger studies using lower doses have found mixed or no evidence of REM suppression.17PubMed. Cannabis and sleep architecture: A systematic review and meta-analysis
What does show up consistently is the flip side: stopping cannabis after regular use reliably disrupts sleep. Withdrawal is associated with shorter total sleep time, longer time to fall asleep, and REM rebound, where the brain catches up on the REM sleep it may or may not have been missing.17PubMed. Cannabis and sleep architecture: A systematic review and meta-analysis This creates a cycle that many users recognize: cannabis becomes the only thing that lets them sleep well, not because it is inherently great for sleep, but because quitting makes sleep temporarily worse.
Tolerance, Dependence, and Recovery
Regular cannabis use causes the brain to dial down its cannabinoid receptors. In chronic daily smokers, CB1 receptor availability in the cortex and limbic areas drops by roughly 20 percent compared to non-users.18PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers This downregulation is what drives tolerance: you need more cannabis to get the same effect because there are fewer receptors available to respond. Animal and human studies confirm that CB1 receptor expression drops and the receptors become less sensitive with chronic use.19PubMed Central. Mechanisms of cannabinoid tolerance
The encouraging part of this story is how quickly the brain bounces back. Imaging studies show that the gap in CB1 receptor availability between dependent users and non-users largely disappears after just two days of abstinence. After about four weeks without cannabis, there were no significant differences in receptor availability between former heavy users and people who had never used.20PubMed Central. Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis A separate study confirmed that the receptor recovery was region-specific, occurring in the same cortical areas where the deficit had been observed, though the hippocampus was slower to recover.18PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers The withdrawal symptoms during those early days of abstinence, irritability, insomnia, reduced appetite, are real and correlated with the rate of receptor recovery, but they are generally manageable and temporary.
The Gut Paradox
Cannabis is widely known for relieving nausea and stimulating appetite, effects that have legitimate medical applications for people undergoing chemotherapy or living with wasting conditions. But chronic, heavy use can produce the opposite: a condition called cannabinoid hyperemesis syndrome, which causes severe, uncontrollable vomiting, nausea, and abdominal pain. The exact mechanism is not fully understood, and the condition is paradoxical by definition, occurring in the very people who might expect cannabis to settle their stomach.21PubMed Central. Cannabinoid Hyperemesis Syndrome: A Rising Complication It tends to resolve when someone stops using cannabis and returns if they start again. Emergency departments have seen a rise in cases as cannabis has become more widely available and higher-potency products have entered the market.
Pregnancy and Fetal Development
Cannabis use during pregnancy is associated with a cluster of concerning outcomes. A systematic review of 13 studies found that children of mothers who used cannabis during pregnancy faced higher rates of sleep cycle disorders, memory problems, hyperactivity, low birth weight, prematurity, and changes in brain development, particularly in the amygdala.22European Journal of Midwifery. Cannabis use during pregnancy and its effect on the fetus, newborn and later childhood: A systematic review A separate study found that pregnant cannabis users had roughly four times the odds of preterm birth and similarly elevated odds of their infant needing respiratory support or assisted ventilation after delivery.23North American Proceedings in Gynecology & Obstetrics. Assessment of Marijuana Use During Pregnancy and its Effects on Neonatal Outcomes Because THC crosses the placenta, the fetal brain is exposed to it during critical periods of development, and since it cannot metabolize the drug as efficiently as an adult, the exposure may be disproportionately potent.
The Immune System
The CB2 receptor, the cannabinoid receptor found mainly on immune cells, ties cannabis directly into the immune system. Its role appears most significant during inflammation, when the number of available CB2 receptors increases. Research into CB2 signaling suggests that cannabinoids can dampen certain inflammatory pathways. In animal models of autoimmune disease, selectively activating CB2 receptors reduced the differentiation of certain pro-inflammatory immune cells and decreased their accumulation in the central nervous system.24PubMed Central. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS This is one reason cannabinoids are being investigated as potential treatments for conditions like multiple sclerosis and other neuroinflammatory diseases.3PubMed Central. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation But the immune suppression that could be therapeutic in an overactive immune system becomes a liability for someone fighting an infection, which circles back to the increased respiratory infection risk in smokers.
Why the Same Joint Hits People Differently
If you have ever noticed that the same strain of cannabis makes one friend giggly and another friend anxious, genetics is part of the answer. Variations in genes that code for the CB1 receptor and for enzymes that break down the body’s own endocannabinoids can influence how THC affects mood. Research has found that specific variants in the CNR1 gene (which encodes CB1) interact with THC to change emotional states: carriers of one variant experienced increased anger and fatigue from THC, but only in the context of certain other genetic configurations within the same gene.25PubMed Central. CNR1 and FAAH Variation and Affective States Induced by Marijuana Smoking This is still early-stage research, but it begins to explain why cannabis experiences are so inconsistent from person to person and why blanket statements about how weed “makes you feel” are unreliable.
Beyond genetics, the other compounds in cannabis also modulate the experience. Terpenes, the aromatic molecules that give different strains their distinct smells, are not just flavor. Lab research has found that certain terpenes activate CB1 receptors on their own at low levels and, when combined with THC at the ratios naturally found in the plant, can significantly amplify CB1 receptor activation, sometimes several fold beyond what THC alone produces.26PubMed. Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation This lends some scientific support to the idea, long promoted in cannabis culture, that the overall chemical profile of a strain matters and that THC content alone does not predict the experience.
Why Blood THC Levels Do Not Reliably Indicate Impairment
One of the trickiest practical issues with cannabis is measuring when someone is too impaired to drive. Unlike alcohol, where blood alcohol concentration tracks fairly well with impairment, THC in the blood does not behave this way. A study of 30 people found that after 12 hours of abstinence, with no measurable impairment, more than half still had blood THC levels above 5 nanograms per milliliter, the legal threshold in several jurisdictions. Counterintuitively, the people with the highest baseline THC levels in their blood tended to have the shortest duration of actual impairment.27PubMed Central. Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath This is because THC is fat-soluble and accumulates in tissue with regular use, slowly leaking back into the bloodstream long after any psychoactive effect has worn off.
More recent work looking at oral fluid THC levels found somewhat better associations with changes in cognitive performance, but the relationship with actual driving performance on a simulator remained subtle.28PubMed. The use of THC cutoff levels in blood and oral fluid for detecting impairment in frequent cannabis users who smoked cannabis the “evening before” The upshot for policy and for individuals is that a single THC measurement tells you someone has used cannabis, but it does not tell you they are impaired right now. This is a genuine gap in the science that affects everything from roadside testing to workplace drug policies.
Synthetic Cannabinoids Are a Different Animal
Products sold as “synthetic marijuana,” “Spice,” or “K2” deserve a separate mention because they are far more dangerous than plant cannabis. These are lab-made compounds sprayed onto dried plant material, and they bind to the same CB1 and CB2 receptors but with much higher potency and often without the partial-agonist ceiling that limits THC’s effects. The adverse effects include respiratory difficulties, high blood pressure, rapid heart rate, chest pain, muscle twitches, acute kidney failure, severe anxiety, agitation, psychosis, suicidal thinking, and significant cognitive impairment.29PubMed Central. Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective Because these products are constantly reformulated to dodge regulations, users rarely know exactly what chemical they are consuming or at what dose.
Age May Flip the Script on Brain Effects
Most cannabis research focuses on young adults, where the findings tend toward harm. But intriguing preliminary work suggests the relationship between cannabis and the brain may look different as people age. A study of middle-aged and older adults found that lifetime cannabis use was actually associated with larger volumes in CB1-rich brain regions, including the caudate, putamen, hippocampus, and amygdala, the opposite of what is typically seen in younger heavy users.30PubMed Central. Lifetime Cannabis Use Is Associated with Brain Volume and Cognitive Function in Middle-Aged and Older Adults An animal study echoed this theme: cannabis smoke exposure tended to increase inflammatory markers in the hippocampus of younger mice but decrease them in older mice, suggesting the aging brain may respond to cannabinoids in a fundamentally different way.31PubMed Central. Effects of sub-chronic cannabis smoke exposure on inflammatory markers in serum and brain in younger and older mice This does not mean older adults should start using cannabis for brain health. The research is too early and too limited for that. But it does suggest that age is a critical variable that most public messaging about cannabis ignores, and that the harms documented in young users cannot simply be extrapolated to everyone.